The recently published Government response to consultation on the future regulation of medical devices in the United Kingdom by the MHRA is a defining moment for the medical device industry with far-reaching implications.

The MHRA report does answer many concerns voiced by the industry but it also raises some challenging new questions that any medical device or IVD company operating in the UK will need to face.

To help medical device companies easily understand the implications of these proposals on their devices and their business operations in the UK, our Medical Device regulatory specialists, using their decades of experience in the sector, have summarised the key issues as we see them relating to the key facets of the industry: devices, software and in vitro medical devices.

Session 1: A breakdown of the key proposals for all devices and their likely implications, including the UK's 'new way' for regulating software medical devices (Tuesday 19 July 09:00 - 10:00 BST)

Session 2: The impact of the new provisions applicable solely to in vitro diagnostic medical devices (Thursday 21 July 09:00 – 09:35 BST)

You can sign up to either or both sessions.   

Please join us for what promise to be concise and highly informative sessions that give you an early start to successfully navigating medical device regulations in post-Brexit UK.